AU2014903514A0 - Markers of Disease Susceptibility and Onset and Uses Therefor - Google Patents

Markers of Disease Susceptibility and Onset and Uses Therefor

Info

Publication number
AU2014903514A0
AU2014903514A0 AU2014903514A AU2014903514A AU2014903514A0 AU 2014903514 A0 AU2014903514 A0 AU 2014903514A0 AU 2014903514 A AU2014903514 A AU 2014903514A AU 2014903514 A AU2014903514 A AU 2014903514A AU 2014903514 A0 AU2014903514 A0 AU 2014903514A0
Authority
AU
Australia
Prior art keywords
onset
markers
disease susceptibility
uses therefor
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014903514A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Original Assignee
Australian National University
Filing date
Publication date
Application filed by Australian National University filed Critical Australian National University
Publication of AU2014903514A0 publication Critical patent/AU2014903514A0/en
Priority to PCT/AU2015/050516 priority Critical patent/WO2016033650A1/en
Abandoned legal-status Critical Current

Links

AU2014903514A 2014-09-03 2014-09-03 Markers of Disease Susceptibility and Onset and Uses Therefor Abandoned AU2014903514A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2015/050516 WO2016033650A1 (en) 2014-09-03 2015-09-03 Markers of disease susceptibility and onset and uses therefor

Publications (1)

Publication Number Publication Date
AU2014903514A0 true AU2014903514A0 (en) 2014-09-18

Family

ID=

Similar Documents

Publication Publication Date Title
IL250415B (en) Anti-pdl- antibodies and methods of use thereof
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3179907A4 (en) Ecg patch and methods of use
ZA201702545B (en) Neuroactive compounds and methods of use thereof
EP3377070A4 (en) Compounds and methods of their use
EP3191524A4 (en) Macropinocytosing human anti-cd46 antibodies and targeted cancer therapeutics
EP3160498A4 (en) Il-15-based molecules and methods of use thereof
EP3204360A4 (en) Therapeutic compounds and uses thereof
GB201403093D0 (en) Therapeutic compounds and their use
IL251988A0 (en) Glycan-interacting compounds and methods of use
IL253160B (en) Cancer markers and methods of use thereof
EP3094346A4 (en) Vista antagonist and methods of use
EP3240576A4 (en) Methods of transdifferentiation and methods of use thereof
EP3200806A4 (en) Nanofiber structures and methods of synthesis and use thereof
LT3089971T (en) Compounds and methods of use
EP3265476A4 (en) Protoxin-ii variants and methods of use
EP3277304A4 (en) Protoxin-ii variants and methods of use
EP3179994A4 (en) Modified mito-metformin compounds and methods of synthesis and use thereof
ZA201606450B (en) Compounds and their methods of use
EP3206481A4 (en) Herbicide tolerance genes and methods of use thereof
EP3121282A4 (en) Novel samdori-2 gene and use thereof
EP3107546A4 (en) Therapeutic methods employing noribogaine and related compounds
EP3197470A4 (en) Cis-gnetin h and trans-gnetin h as therapeutic agents
GB201400472D0 (en) Biochemical Markers for pulmonary and other diseases
EP3187488A4 (en) Novel amino-phenyl-sulfonyl-acetate derivative and use thereof